UpFront Diagnostics obtient le marquage CE pour LVOne, premier test sanguin rapide au monde destiné au diagnostic de l’AVC

LVOne states that it is the only blood-based diagnostic kit for stroke diagnosis to have received CE marking. The regulatory clearance supports commercial differentiation in the European medical-diagnostics market, although the article provides no revenue, clinical-performance, or sales data.